Bussink J - Search Results

1

PET-CT for response assessment and treatment adaptation in head and neck cancer.

Bussink J, van Herpen CM, Kaanders JH, Oyen WJ. Bussink J, et al. Lancet Oncol. 2010 Jul;11(7):661-9. doi: 10.1016/S1470-2045(09)70353-5. Epub 2010 Mar 10. Lancet Oncol. 2010. PMID: 20226735 Review.

2

Pharmacology and toxicity of nicotinamide combined with domperidone during fractionated radiotherapy.

Bussink J, Stratford MR, van der Kogel AJ, Folkes LK, Kaanders JH. Bussink J, et al. Radiother Oncol. 2002 Jun;63(3):285-91. doi: 10.1016/s0167-8140(02)00072-5. Radiother Oncol. 2002. PMID: 12142092

3

Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.

Ljungkvist AS, Bussink J, Rijken PF, Kaanders JH, van der Kogel AJ, Denekamp J. Ljungkvist AS, et al. Among authors: bussink j. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):215-28. doi: 10.1016/s0360-3016(02)02938-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182995

4

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ. Kaanders JH, et al. Among authors: bussink j. Cancer Res. 2002 Dec 1;62(23):7066-74. Cancer Res. 2002. PMID: 12460928 Clinical Trial.

5

ARCON: a novel biology-based approach in radiotherapy.

Kaanders JH, Bussink J, van der Kogel AJ. Kaanders JH, et al. Among authors: bussink j. Lancet Oncol. 2002 Dec;3(12):728-37. doi: 10.1016/s1470-2045(02)00929-4. Lancet Oncol. 2002. PMID: 12473514 Review.

6

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.

Bussink J, Kaanders JH, van der Kogel AJ. Bussink J, et al. Radiother Oncol. 2003 Apr;67(1):3-15. doi: 10.1016/s0167-8140(03)00011-2. Radiother Oncol. 2003. PMID: 12758235 Review.

7

Clinical studies of hypoxia modification in radiotherapy.

Kaanders JH, Bussink J, van der Kogel AJ. Kaanders JH, et al. Among authors: bussink j. Semin Radiat Oncol. 2004 Jul;14(3):233-40. doi: 10.1016/j.semradonc.2004.04.002. Semin Radiat Oncol. 2004. PMID: 15254866 Review.

8

Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.

van Herpen CM, Bussink J, van der Kogel AJ, Peeters WJ, van der Voort R, van Schijndel A, de Wilde PC, Adema GJ, de Mulder PH. van Herpen CM, et al. Among authors: bussink j. Anticancer Res. 2005 Mar-Apr;25(2A):1015-21. Anticancer Res. 2005. PMID: 15868941 Free article.

9

Hypoxic cell turnover in different solid tumor lines.

Ljungkvist AS, Bussink J, Kaanders JH, Rijken PF, Begg AC, Raleigh JA, van der Kogel AJ. Ljungkvist AS, et al. Among authors: bussink j. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1157-68. doi: 10.1016/j.ijrobp.2005.03.049. Int J Radiat Oncol Biol Phys. 2005. PMID: 15913908

10

Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.

Troost EG, Bussink J, Kaanders JH, van Eerd J, Peters JP, Rijken PF, Boerman OC, van der Kogel AJ. Troost EG, et al. Among authors: bussink j. Radiother Oncol. 2005 Aug;76(2):194-9. doi: 10.1016/j.radonc.2005.06.031. Radiother Oncol. 2005. PMID: 16024110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page